Adrenergic beta-Antagonists

"Adrenergic beta-Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Descriptor ID	D000319
MeSH Number(s)	D27.505.519.625.050.200.200 D27.505.696.577.050.200.200
Concept/Terms	Adrenergic beta-Antagonists Adrenergic beta-Antagonists Adrenergic beta Antagonists beta-Antagonists, Adrenergic beta-Adrenergic Receptor Blockaders Blockaders, beta-Adrenergic Receptor Receptor Blockaders, beta-Adrenergic beta Adrenergic Receptor Blockaders beta-Adrenergic Blockers Blockers, beta-Adrenergic beta Adrenergic Blockers beta-Blockers, Adrenergic Adrenergic beta-Blockers beta Blockers, Adrenergic Adrenergic beta-Receptor Blockaders Adrenergic beta Receptor Blockaders Blockaders, Adrenergic beta-Receptor beta-Receptor Blockaders, Adrenergic beta-Adrenergic Blocking Agents Agents, beta-Adrenergic Blocking Blocking Agents, beta-Adrenergic beta Adrenergic Blocking Agents

Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Antagonists".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Adrenergic Agents [D27.505.519.625.050]
Adrenergic Antagonists [D27.505.519.625.050.200]
Adrenergic beta-Antagonists [D27.505.519.625.050.200.200]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Adrenergic Agents [D27.505.696.577.050]
Adrenergic Antagonists [D27.505.696.577.050.200]
Adrenergic beta-Antagonists [D27.505.696.577.050.200.200]

Below are MeSH descriptors whose meaning is related to "Adrenergic beta-Antagonists".

Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Antagonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adrenergic beta-Antagonists" by people in this website by year, and whether "Adrenergic beta-Antagonists" was a major or minor topic of these publications.

Bar chart showing 131 publications over 29 distinct years, with a maximum of 10 publications in 1999

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	5	2	7
1997	2	1	3
1998	2	1	3
1999	7	3	10
2000	6	2	8
2001	0	4	4
2002	3	5	8
2003	3	4	7
2004	2	2	4
2005	3	6	9
2006	2	4	6
2007	1	5	6
2008	3	6	9
2009	1	2	3
2010	1	4	5
2011	4	2	6
2012	1	2	3
2013	0	2	2
2014	1	4	5
2015	1	0	1
2016	5	0	5
2017	2	1	3
2018	1	0	1
2019	2	1	3
2020	2	0	2
2021	1	2	3
2022	0	1	1
2023	2	1	3
2024	0	1	1

Below are the most recent publications written about "Adrenergic beta-Antagonists" by people in Profiles.

Biswas S, Toro M, Horgan R, McLaren RA, Berghella V, Al-Kouatly HB. Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2024 10; 6(10):101459.

View in: PubMed
Lefkowitz RJ, Rockman HA, Shim PJ, Liu S, Ahn S, Pani B, Rajagopal S, Shenoy SK, Bouvier M, Benovic JL, Liggett SB, Ruffolo RR, Bristow MR, Packer M. How carvedilol does not activate ?2-adrenoceptors. Nat Commun. 2023 11 30; 14(1):7866.

View in: PubMed
Polintan ET, Monsalve R, Menghrajani RH, Sirilan KY, Nayak SS, Abdelmaseeh P, Patarroyo-Aponte G, Lo KB, Dani SS. Combination prophylactic amiodarone with beta-blockers versus beta-blockers in atrial fibrillation after cardiac surgery: A systematic-review and meta-analysis. Heart Lung. 2023 Nov-Dec; 62:256-263.

View in: PubMed
Nakao K, Dafaalla M, Nakao YM, Wu J, Nadarajah R, Rashid M, Mohammad H, Sumita Y, Nakai M, Iwanaga Y, Miyamoto Y, Noguchi T, Yasuda S, Ogawa H, Mamas MA, Gale CP. Comparison of care and outcomes for myocardial infarction by heart failure status between United Kingdom and Japan. ESC Heart Fail. 2023 04; 10(2):1372-1384.

View in: PubMed
Zaghlol R, Ghazzal A, Radwan S, Zaghlol L, Hamad A, Chou J, Ahmed S, Hofmeyer M, Rodrigo ME, Kadakkal A, Lam PH, Rao SD, Weintraub WS, Molina EJ, Sheikh FH, Najjar SS. Beta-blockers and Ambulatory Inotropic Therapy. J Card Fail. 2022 08; 28(8):1309-1317.

View in: PubMed
Nakafero G, Grainge MJ, Valdes AM, Townsend N, D Mallen C, Zhang W, Doherty M, Mamas M, Abhishek A. ?-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score-matched cohort study. Rheumatology (Oxford). 2021 12 01; 60(12):5686-5696.

View in: PubMed
Arbabi A, Bao X, Shalaby WS, Razeghinejad R. Systemic side effects of glaucoma medications. Clin Exp Optom. 2022 03; 105(2):157-165.

View in: PubMed
Boyce TG, Ballone NT, Certa KM, Becker MA. The Use of ?-Adrenergic Receptor Antagonists in Psychiatry: A Review. J Acad Consult Liaison Psychiatry. 2021 Jul-Aug; 62(4):404-412.

View in: PubMed
Shukla AG, Razeghinejad R, Myers JS. Balancing treatments for patients with systemic hypertension and glaucoma. Expert Opin Pharmacother. 2020 Dec; 21(18):2225-2230.

View in: PubMed
Wang S, M?ller J, Goeder D, Araujo CG, Silva CGSE, Myers J. Effect of Beta-Blocker Use on Exercise Heart Rate Gradient and Reclassification of Mortality Risk in Patients Referred for Exercise Testing. Am J Cardiol. 2020 09 01; 130:152-156.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement